Stryker hip replacement lawsuits involving the company’s LFIT Anatomic CoCr V40 Femoral Heads are moving forward, following the issuance of a new Case Management Order in New Jersey’s Bergen County Superior Court.
According to the August 1st Order, the multicounty litigation convened its most recent conference on July 31, 2017. The Order also directs the parties to meet and confer on a number of issues, including:
Stryker’s LFIT Anatomic CoCr V40 Femoral Heads are constructed from a chromium/cobalt alloy, and can be combined with several of the company’s modular hip implant components, including:
Plaintiffs participating in the LFIT V40 femoral head litigation claim that Stryker has known for years that the components were defective, but downplayed their dangers and failed to provide doctors and patients with appropriate safety warnings.
Stryker recalled certain LFIT CoCr V40 Femoral Heads in August 2016, after the components had been associated with a “higher than expected number of complaints involving taper lock failure.” Taper lock failure can result in adverse local tissue reactions, dislocation, and other debilitating complications that may cause premature failure of the implant and the need for revision surgery.
All of the Stryker hip components affected by the LFIT V40 femoral head recall were manufactured prior to 2011. The recalled catalog numbers and sizes include:
The U.S. Food & Drug Administration (FDA) designated Stryker’s action a Class II recall, which indicates that the affected devices could cause temporary or medically reversible health effects.
It should be noted that Stryker hip lawsuits involving non-recalled LFIT V40 femoral heads are also eligible for inclusion in the Bergen County litigation.